Monoclonal antibody EP-5C7 (PDL BioPharma)

N/A

Report date: 2022/01/14 13:23:58

Base Information

Drug NameMonoclonal antibody EP-5C7 (PDL BioPharma)

Drug Alias NameHuEP5C7HuEP5C7 MAbMonoclonal antibody 5C7.29SMART anti-E/P-selectin antibodyAnti-E/P-selectin monoclonal antibody - Protein Design Labs +[6]

ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody > Monoclonal antibody humanized

Mechanisms of ActionP-selectin inhibitorsSelectin E inhibitors

TargetsSelectin EP-selectin

Therapy Area/IndicationsShockAutoimmune DiseasesPsoriasis +[5]

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryN/A

CombinationsNo

Global Highest StatusDiscontinued (Phase 1 Clinical)

Highest Status in ChinaN/A

Originator CompaniesPdl Biopharma Inc

China Registration ClassN/A

Develop Information

Active CompaniesN/A

Inactive CompaniesPdl Biopharma Inc

Active IndicationsN/A

Inactive IndicationsShockAutoimmune DiseasesPsoriasis +[5]

Other Information

ATC CodeN/A